4 sources checked · 2 source groups included · 58m ago
Still Watching
Dartmouth patients among first to get new drug that fights pancreatic cancer
WMUR9 (Hearst, Manchester NH) and WORLD Magazine describe the same event in different terms.
0 Left1 Center3 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 27, 2026 at 5:10 PM, this is how Optics News reads the wording differences in this story.
What happenedA new drug has nearly doubled the survival rate for people suffering from pancreatic cancer, and doctors say it might be able to treat other types of cancer, as well.
The headline splitThe center frames it as "Dartmouth patients among first to get new drug that fights pancreatic cancer". The right frames it as "FDA approves breakthrough drug to treat advanced pancreatic cancer. “A late-stage clinica...".
Match confidenceDeveloping. The source map is still developing. Keep watching for more sources to join.
Same-event confidenceMedium
4 sources across 2 bias buckets agree on the event.
Framing confidenceHidden
Wording-gap score hidden — source map is too narrow to read confidently.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.
Optics keeps watching for pickup.
CenterDartmouth patients among first to get new drug that fights pancreatic cancer
WMUR9 (Hearst, Manchester NH) · Center · News report
Right / center-rightHope on the horizon with new drug to fight one of the deadliest cancers
Dartmouth patients among first to get new drug that fights pancreatic cancer
A new drug has nearly doubled the survival rate for people suffering from pancreatic cancer, and doctors say it might be able to treat other types of cancer, as well.
Hope on the horizon with new drug to fight one of the deadliest cancers
The world may have taken one giant step closer to curing one of the deadliest forms of cancer. The U.S. Food and Drug Administration approved the use […]
HEALTH: FDA approves breakthrough drug to treat advanced pancreatic cancer. “A late-stage clinical t
FDA approves breakthrough drug to treat advanced pancreatic cancer. “A late-stage clinical trial with 500 patients showed that the median overall survival nearly doubled to more than 13 mon...
